Rise Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.6K | Hold |
430
| – | – | 0.01% | 441 |
|
|
2025
Q1 | $30.4K | Buy |
+430
| New | +$30.4K | 0.01% | 322 |
|
|
2024
Q4 | – | Sell |
-22
| Closed | -$1.55K | – | 1129 |
|
|
2024
Q3 | $1.55K | Hold |
22
| – | – | ﹤0.01% | 1141 |
|
|
2024
Q2 | $1.81K | Hold |
22
| – | – | ﹤0.01% | 1128 |
|
|
2024
Q1 | $1.92K | Hold |
22
| – | – | ﹤0.01% | 1143 |
|
|
2023
Q4 | $2.12K | Hold |
22
| – | – | ﹤0.01% | 461 |
|
|
2023
Q3 | $1.95K | Buy |
22
+15
| +214% | +$1.33K | ﹤0.01% | 470 |
|
|
2023
Q2 | $607 | Hold |
7
| – | – | ﹤0.01% | 606 |
|
|
2023
Q1 | $681 | Hold |
7
| – | – | ﹤0.01% | 703 |
|
|
2022
Q4 | $724 | Hold |
7
| – | – | ﹤0.01% | 684 |
|
|
2022
Q3 | $1K | Hold |
7
| – | – | ﹤0.01% | 602 |
|
|
2022
Q2 | $1K | Hold |
7
| – | – | ﹤0.01% | 611 |
|
|
2022
Q1 | $1K | Hold |
7
| – | – | ﹤0.01% | 584 |
|
|
2021
Q4 | $618 | Buy |
+7
| New | +$618 | ﹤0.01% | 617 |
|